title: Borderline epithelial ovarian tumors: a single center experience.
abstract: OBJECTIVE
  To evaluate the clinical outcomes of the patients treated for borderline ovarian tumor (BOT).
  
  
  METHODS
  In this retrospective study, records of the patients between November 2001 and December 2012 who underwent surgery and whose final pathological diagnosis were BOT were retrieved.
  
  
  RESULTS
  During the study period, 78 patients were diagnosed as BOT. The patho- logical diagnoses of the tumors were serous in 26 (33.3%) and mucinous in 52 patients (66.6 %), respectively. Accuracy of frozen section diagnosis was observed in 63 of 89 patients (70.7%). Sixty-eight women (87.1%) underwent complete staging procedure. According to final pathological diagnoses, Stage IA, IB, and IC were found in 52 (67%), five (6.5%), and seven (9%) patients, respectively. FIGO Stages IIC and IIIC were found in one case in each (1.25%). Remaining 12 patients were classified as unstaged (15%). The median follow-up time was 63 months. The authors observed only one recurrence (1.3%) and that patient died of disease.
  
  
  CONCLUSIONS
  The survival rate in patients with BOTs confined to the ovary is excellent. Surgical staging procedure can be omitted in the patients with grossly apparent Stage I mucinous tumors.
authors.affiliation: Department of Obstetrics and Gynecology, Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey.
authors.forename: C
authors.initials: C
authors.lastname: Numanoglu
authors.forename: V
authors.initials: V
authors.lastname: Ulker
authors.forename: O
authors.initials: O
authors.lastname: Kuru
authors.forename: O
authors.initials: O
authors.lastname: Akbayir
authors.forename: M
authors.initials: M
authors.lastname: Sakinci
authors.forename: A
authors.initials: A
authors.lastname: Akyol
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000077216:Carcinoma, Ovarian Epithelial; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D009375:Neoplasms, Glandular and Epithelial / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D015996:Survival Rate